4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011483
Principal Accounting Officer sold 152 shares at $76.45 ($11,620)
- Principal Accounting Officer gave up 278 shares (to pay taxes)
- Principal Accounting Officer acquired 790 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alenson Carman Principal Accounting Officer | 2018-09-28 | Sale | −152 | $76.45 | $11,620 | 0 | D: show line 1 in the form |
| Alenson Carman Principal Accounting Officer | 2019-02-16 | Option exercise | +790 | 790 | D: show line 2 in the form | ||
| Alenson Carman Principal Accounting Officer | 2019-02-19 | Shares withheld for taxes | −278 | $58.03 | $16,132 | 512 | D: show line 3 in the form |
| Open-market sales · 152 sh · avg $76.45 · $11,620 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alenson Carman Principal Accounting Officer | 2019-02-16 | Option exercise · Restricted stock units | −790 | 1,580 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…